User talk:Mtvan

. Fluorescent probes for biological zinc and nitric oxide reveal multiple pathways in which these inorganic species are interconnected in biology. Studies of Zn/NO synergism in the neuronal, cardiovascular, and immune systems which are benifits way. Nervous System +The involvement of both Zn(II) and NO in a variety of neurological dysfunctions such as Alzheimer’s disease. The neurotoxic effects of both inorganic species, has sparked interest in studying two analytes in the central nervous system. + The treatment of hippocampal neurons with exogenous NO donors, including sodium nitroprusside or spermine NONOate, resulted in mobilization and accumulation of Zn(II) in brain tissue, as detected by TSQ fluorescence and Timm staining 139) Cardiovascular System + Increased fluorescence from Zinquin-E was observed in both the cytoplasm and nucleus (143). And NO has vasodilatory effects in the cardiovascular system, the NO/Zn(II) interplay has also been implicated in hypoxia-mediated NO biosynthesis that contributes to vasoconstriction. + PKG inhibition was observed and NO was detected byDAF-FM.Morphinemobilized intracellular Zn by the NO/cGMP/PKG pathway and inhibited a mitochondrial permeability transition pore opening by inactivation of GSK-3β. Immune System + Zinc and nitric oxide participate in processes orchestrated by the immune system to defend against pathogens. Zinc deficiency leads to impaired immune function and increased susceptibility to infection (149). + Exposure to endotoxins, such as proinflammatory cytokines and/or LPS, prompts expression of the iNOS and hence increased NO production under inflammatory conditions.

Main Talk Page
Please do not add material to the Main talk page unless it is related to the Main Page. If you continue to do this, you could be blocked. --Jomegat (discuss • contribs) 02:18, 30 October 2011 (UTC)

Action on Chronic Diseases
According to the science magazine, heads of U.N. member states will gather to discuss the growing pandemic of no communicable diseases such as cancer and diabetes. The huge successful meeting on HIV/AIDS, Tuberculosis and Malaria, but some public health experts and advocates who had high hopes for the meeting find their enthusiasm a but quashed. In both wealthy and poor countries, NCDs kill more people than all other diseases combined, for 63%of deaths in 2008. From the long list of chronic diseases, who identified four priorities such as cancer, diabetes, cardiovascular disease, and respiratory disease. And the four major risk factors such as smoking, unhealthy diet, lack of physical activity, and alcohol abuse

Tweezing apart amyloids.
There is one of a new research about the tweezing apart amyloids. Aclawlike molecule cannot ravel the protein snarls behind diseases such as Alzheimer’s and Parkinson’s can sever as the basis for a new strategy to treat a broad range of protein-misfolding diseases. There is the protein clumps associated with diseases are called amyloids. When normal proteins in the cell unfold and then stick together in aggregates that can damage cells, it will be formed. The earlier research on amyloids suggests the amino acid lysine in proteins acts as an amyloid glue. Lysine can associate with complementary surface such as an amino acid, other small molecule, proteins through both hydrophobic and electrostatic interactions, two forces that drive protein aggregation. Gal Bitan of the University of California, Los Angeles, has been studying amyloid-beta for ten years, the protein associated with Alzheimer’s disease searching a molecule, which is called CLRo1 that binds lysine. This lysine is more tweezer. CLRo1 binds to lysine weakly that it won’t interfere with the work of healthy proteins, Bitan said. Mixing the CLRo1 with protein and minitored the formation of amyloids by using a dye that fluoresces binding to common structural. CLRo1 breaks down previously formed amyloids. Amyloid-beta is just one of several proteins that aggregate into noxious clumps, each amyloid disease has own signature protein.

New Antivirals and Drug Resistance
There are antiviral drugs are medication for treating viral infection. Like antibiotic for bacteria, specific antivirals are used for specific viruses. Most antibiotics, antiviral always do not destroy their target pathogen; instead they inhibit their development.

The most antiviral drugs available ate to help deal with HIV, helps virus, the hepatitis b and C virus which can cause liver cancer, and influences A and B virus. There are new antiviral and drug resistance, so the target for antiviral should be function. Sites. The failure of antibody-medicated immunity to combat viral strain variation is usually a failure of the antibody to the target functions. Furthermore, the protease inhibitors have made as part of the anti-HIV armamentarium. And there are four classes of antiviral are presented influenza virus neuraminidase inhibitors, HIV protease inhibitor, antibodies, and protein based fusion inhibitors.

The neuraminidase inhibitors for treatment and prevention of influenza virus infection are the structure based drug discovery. It is a homotetrameric glycoprotein anchored by fibrous stalk in the viral membrane. The enzyme liberates n-acetyl neuraminic aicd (Neu5Ac) form alpha 2-3 or alpha 2-7 linkages to galactose. And the crystal structures of representatives of the N2, N9, and type B neuraminidase inhibitor drug class.

Neuraminidase Inhibitors is replacement of the C4-hydroxyl moiety of Neu5Ac2en with amino or guanidine substituents, designed to optimize chemical and shape complementarily to the enzyme, 100 and 10,000-fold improvements in binding potency. A more radical redesign of the pyran to a carbocyclic scaffold led to the discovery of the active neuraminidase inhibitor oseltamivir.

Resistance is to attempts to culture neuraminidase inhibitor-resistant influenza with Neu5Ac2en analogs resulted in viruses with off target mutations in the receptor-binding site of the hemagglutinin for the receptor and the efficiency of destruction of the receptor by the neuraminidase. More addition, the cleavage of the Gag and Pol polyproteins of HIV by the viral protease is essential step in maturation of the virus. So, the protease is a symmetric dinner with a pair of active site aspartyl residue D25, D25’ in close proximity to the symmetry axes and the scissile bond of the substrate. Indeed, protease drug resistant variants with mutations in both the enzyme active site and in the substrate have been described. Another thing is the inhibitor of viral membrane fusion. For HIV, a structure for gp160 remains elusive, but numerous studies of the post the postfusion conformation of gp41 have informed the exploitation of the fusion machinery as a drug target. Summary, the keys of antivirals drug and drug resistance are anitibody, HIV, influenza.